» Articles » PMID: 25592661

Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis

Overview
Specialty Gastroenterology
Date 2015 Jan 17
PMID 25592661
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Levels of circulating of sex hormones are associated with glucose metabolism and adiposity, but little is known about their association with ectopic fat. We aimed to characterize the association between circulating sex hormones and liver fat.

Methods: We conducted a cross-sectional analysis by using data from the Multiethnic Study of Atherosclerosis to assess the association of the circulating levels of bioavailable testosterone, estradiol, dehydroepiandrosterone, and sex hormone binding globulin (SHBG) with fatty liver. Fatty liver was defined as a reduction of ≤40 Hounsfield units, measured by computed tomography, in 2835 postmenopausal women and 2899 men (45-84 years old; white, black, Hispanic, or Chinese) at 6 centers in the United States.

Results: Women in the highest tertile of bioavailable testosterone were significantly more likely to have fatty liver than women in the lowest tertile (odds ratio, 1.77; 95% confidence interval, 1.07-2.92). We found an even greater difference for level of estradiol (odds ratio, 2.49; 95% confidence interval, 1.41-4.39) after adjusting for age, race/ethnicity, waist-to-hip ratio, hypertension, total and high-density lipoprotein cholesterol, smoking, insulin sensitivity, and hormone replacement therapy use. Men in the highest tertile of estradiol level were significantly more likely to have fatty liver than men in the lowest tertile (odds ratio, 2.10; 95% confidence level, 1.29-3.40). Men in the highest tertile of SHBG were less likely to have fatty liver than those in the lowest tertile (odds ratio, 0.46; 95% confidence interval, 0.27-0.77). Other associations between hormone levels and fatty liver were not statistically significant.

Conclusions: On the basis of a cross-sectional study, postmenopausal women with high levels of bioavailable testosterone are at greater risk for fatty liver. In men, higher levels of SHBG are associated with reduced risk for fatty liver. Higher levels of estradiol are associated with fatty liver in both sexes. This pattern is consistent with the sex-specific associations of sex hormones with other cardiometabolic risk factors.

Citing Articles

Association between the ratio of serum uric acid to high-density lipoprotein cholesterol and liver fat content: evidence from a Chinese health examination dataset.

Liu A, Sun Y, Qi X, Zhou Y, Zhou J, Li Z Sci Rep. 2024; 14(1):31397.

PMID: 39733068 PMC: 11682173. DOI: 10.1038/s41598-024-83013-2.


Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?.

Duan H, Gong M, Yuan G, Wang Z J Clin Exp Hepatol. 2024; 15(2):102459.

PMID: 39722783 PMC: 11667709. DOI: 10.1016/j.jceh.2024.102459.


Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD.

Luo S, Weng X, Xu J, Lin H Front Med (Lausanne). 2024; 11:1443811.

PMID: 39211343 PMC: 11357965. DOI: 10.3389/fmed.2024.1443811.


Hypogonadism and nonalcoholic fatty liver disease.

Papadimitriou K, Mousiolis A, Mintziori G, Tarenidou C, Polyzos S, Goulis D Endocrine. 2024; 86(1):28-47.

PMID: 38771482 DOI: 10.1007/s12020-024-03878-1.


Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.

Cao M, Cui B Cardiovasc Diabetol. 2024; 23(1):126.

PMID: 38614964 PMC: 11016216. DOI: 10.1186/s12933-024-02222-1.


References
1.
Tian G, Sun Y, Pang C, Tan A, Gao Y, Zhang H . Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev. 2012; 13(4):381-7. DOI: 10.1111/j.1467-789X.2011.00978.x. View

2.
Rohrmann S, Shiels M, Lopez D, Rifai N, Nelson W, Kanarek N . Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control. 2011; 22(8):1141-51. PMC: 3818569. DOI: 10.1007/s10552-011-9790-z. View

3.
Chalasani N, Younossi Z, Lavine J, Diehl A, Brunt E, Cusi K . The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012; 142(7):1592-609. DOI: 10.1053/j.gastro.2012.04.001. View

4.
Zeb I, Li D, Nasir K, Katz R, Larijani V, Budoff M . Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol. 2012; 19(7):811-8. PMC: 3377794. DOI: 10.1016/j.acra.2012.02.022. View

5.
Kim S, Kwon H, Park J, Cho B, Kim D, Oh S . A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol. 2012; 12:69. PMC: 3406998. DOI: 10.1186/1471-230X-12-69. View